UK HPLC market is projected to grow at a significant CAGR during the forecast period (2020-2026), owing to the the rise in the pharmaceutical R&D expenditure and the increasing focus on the clinical trials. According to the UK Parliament, in 2018, the pharmaceutical industry performed the most R&D in the UK, as compared to other sectors, such as automotive and aerospace. The pharmaceutical R&D performed by UK in 2018 was worth around $6.1 billion. Moreover, the participants in clinical trials are gradually increasing in UK. The UK has a strong clinical research heritage. As per the National Health Services (NHS), the patients participating in clinical research in UK have increased significantly.
There are facts published by the National Institute for Health Research (NIHR) in May 2019, related to the clinical trials in UK-
Browse the full report description UK High-Performance Liquid Chromatography (HPLC) Market Size, Share & Trends Analysis Report by Product Type (Consumables, Instruments, and Accessories), Application (Diagnostics, Clinical Research, Forensics, and Others), and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/uk-hplc-market
Market Coverage
|
Report Elements |
Details |
|
Study Period |
2019-2026 |
|
Base year |
2019 |
|
Forecast period |
2020-2026 |
|
Segments Covered |
By Product Type and by Application |
|
Key Companies Profiled |
Hamilton Bonaduz AG, Merck KGaA,
PerkinElmer Inc., Thermo Fisher Scientific Inc., Verulam Scientific Ltd., and
others |
Key questions addressed by the report
o Recovery Timeline
o Deviation from the pre-COVID-19 forecast
o Most affected segment
o Recommendations
UK HPLC Market – Segmentation
By Product Type
By Application
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/uk-hplc-market